Shionogi Sues To Block Another Generic Fortamet Challenge
Japanese pharmaceutical company Shionogi Inc. launched its latest bid to defend its Type 2 diabetes treatment Fortamet on Friday, suing Nostrum Pharmaceuticals LLC over its effort to market a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article